Alpha-9 Oncology Revenue and Competitors
Estimated Revenue & Valuation
- Alpha-9 Oncology's estimated annual revenue is currently $12.1M per year.
- Alpha-9 Oncology's estimated revenue per employee is $155,000
- Alpha-9 Oncology's total funding is $261M.
Employee Data
- Alpha-9 Oncology has 78 Employees.
- Alpha-9 Oncology grew their employee count by 50% last year.
Alpha-9 Oncology's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | Chief Financial Officer | Reveal Email/Phone |
5 | Chief Business Officer | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | Radiation Safety Officer / EHS Manager | Reveal Email/Phone |
8 | VP, Pharmaceutical Development & External Manufacturing | Reveal Email/Phone |
9 | VP Clinical Operations | Reveal Email/Phone |
10 | SVP, Drug Discovery | Reveal Email/Phone |
Alpha-9 Oncology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Alpha-9 Oncology?
Alpha-9 Oncology is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment of people living with cancer. Applying proprietary technologies and deep-foundational expertise, Alpha-9 is on the forefront of engineering bespoke radiopharmaceuticals that are optimized to selectively deliver radiation to tumor sites while minimizing off-target effects. Alpha-9 is advancing a robust pipeline of novel radiopharmaceuticals with a systematic approach to molecule design that offers broad potential for expansion into several validated oncology targets. Alpha-9 was founded by researchers from the University of British Columbia and BC Cancer, with the goal of improving the lives of patients affected by metastatic cancers.
keywords:N/A
$261M
Total Funding
78
Number of Employees
$12.1M
Revenue (est)
50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 78 | 1% | N/A |
#2 | $10.1M | 78 | -46% | $43.9M |
#3 | $11.3M | 78 | N/A | N/A |
#4 | $11.3M | 78 | 22% | N/A |
#5 | $8M | 78 | -2% | N/A |